Incyte bags Pemazyre FDA approval for cholangiocarcinoma treatment
Pemazyre FDA approval : US biopharma company Incyte has bagged accelerated approval from the US Food and Drug Administration (FDA) for Pemazyre (pemigatinib) for the treatment of cholangiocarcinoma, a rare type of cancer occurring in the bile ducts. The approval is for adult patients having certain types of previously treated, advanced cholangiocarcinoma. According to the […]
Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic cholangiocarcinoma. The priority review for pemigatinib is for the treatment of the condition in previously treated patients having FGFR2 fusions or rearrangements. Cholangiocarcinoma is a rare cancer that occurs […]
Continue reading …
Business News Today
- Carlsberg, Marston’s to create Carlsberg Marston’s Brewing Company in UK
- FRP wraps up Carluccio’s sale to Boparan Restaurant Group
- GE to provide turbines for POWERICA’s Rajkot and Khambaliya wind farms
- KKR to invest $150m in Reliance’s digital services business Jio Platforms
- Rosatom fully commissions Akademic Lomonosov floating nuclear power plant
- Southern Power buys majority stake in Beech Ridge II Wind Facility from Invenergy
- Greenleaf Foods expands frozen portfolio with Field Roast Plant-Based Nuggets
- Popcornopolis rolls out Americorn Popcorn at Sam’s Club
- Winkler Wholesale Grocers selects ShopHero as ecommerce provider
- Lira Style launches Cervello laser hair removal platform
